The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 06, 2026
Snapshot (as of Sep 06, 2026): Roche Holding AG (RHHBF) pays a $9.80 annual dividend, yielding 2.75% at $441.39/share. Next ex-dividend date 2026-03-13. 10 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.75%
Annual Dividend: $9.80 per share
Payout Ratio: 68.5%
Ex-Dividend Date: 2026-03-13
Sector: Healthcare
Years of Dividend History: 25
Roche Holding AG dividend investors are looking at a global pharmaceutical and diagnostics company with 128 years of operating history and a current yield of 2.75%. The company develops oncology, neurology, and immunology therapies while running a diagnostics business that covers cancer, COVID-19, and hepatitis testing across dozens of countries. Trailing annual payments total $9.80 per share. With a beta of 0.347, RHHBF stock moves far less than the broader market, which suits income investors who prioritize low volatility over high yield.
Roche Holding AG pays out 68.5% of earnings as dividends, a payout ratio classified as elevated (60–75%). That level is supported by demand across two entrenched business lines: a pharmaceutical division spanning oncology, immunology, and rare diseases, and a diagnostics arm selling in vitro tests and instruments across multiple continents. Roche Holding AG dividend safety faces its main pressure from that payout ratio itself, which leaves a narrower buffer than lower-payout peers if earnings come under pressure from patent expirations or pricing headwinds.
Roche Holding AG dividend history shows a CAGR of 3.2% per year from 2011 to 2025. Per-share payments grew from $7.09 to $11.01 over that window (2026 data is partial and excluded from the CAGR calculation). The largest annual increase in the window was 13.7% in 2014, though the history also contains at least one year-over-year decline exceeding 5%, so growth has not been linear. At 3.2% annually, the pace keeps income roughly in line with moderate inflation but does not meaningfully accelerate purchasing power.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +3.5% | $9.95 (2022) | $11.01 (2025) |
| 5-Year | +3.8% | $9.14 (2020) | $11.01 (2025) |
| 10-Year | +2.9% | $8.23 (2015) | $11.01 (2025) |
RHHBF fits dividend investors who want moderate, recurring income from a business with broad geographic and therapeutic reach. The current yield of 2.75% sits above the 5-year average of 2.35%, meaning today's entry point delivers more income than the historical norm. Growth is slow at 3.2% per year, and the payout ratio at 68.5% leaves less room for acceleration. The yield classification is moderate (2–4%), which reflects a stock that prioritizes income continuity over yield maximization. The trade-off is clear: Roche Holding AG offers a low-volatility income stream from a diversified healthcare business, but investors accept limited dividend growth in return.
| Payment Date | Amount per Share |
|---|---|
| 2026-03-13 | $12.4084 |
| 2025-03-28 | $11.0120 |
| 2024-03-14 | $10.8667 |
| 2023-03-16 | $10.2152 |
| 2022-03-17 | $9.9464 |
| 2021-03-18 | $9.8041 |
| 2020-03-19 | $9.1408 |
| 2019-03-07 | $8.6282 |
| 2018-03-15 | $8.7329 |
| 2017-03-16 | $8.2377 |
| Year | Total Dividends |
|---|---|
| 2026 | $12.4084 |
| 2025 | $11.0120 |
| 2024 | $10.8667 |
| 2023 | $10.2152 |
| 2022 | $9.9464 |
Project income from RHHBF with the RHHBF dividend calculator or track your full portfolio with the dividend tracker.